Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Clinical Lymphoma & Myeloma
|
May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial
Emilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Haematologica
|
April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Annals of Hematology
|
February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
Leukemia & Lymphoma
|
June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use
Carlos Montalban, Victor Abraira, Luca Arcaini, et al.
British Journal of Haematology
|
August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases
Carlos Montalbán, Víctor Abraira, Luca Arcaini, et al.
British Journal of Haematology
|
March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Blood
|
January 24, 2014
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma
Giovanni Franco, Carla Guarnotta, Barbara Frossi, et al.
Cancer Medicine
|
July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Marc P E André, Patrice Carde, Simonetta Viviani, et al.
International Journal of Hematology
|
November 27, 2008
Advanced mast cell disease: an Italian Hematological Multicenter experience
Livio Pagano, Caterina Giovanna Valentini, Morena Caira, et al.
Blood
|
February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical use
Luca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Clinical Lymphoma & Myeloma
|
May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial
Emilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Haematologica
|
April 6, 2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini, Luigi Rigacci, Francesco Merli, et al.
Annals of Hematology
|
February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
Leukemia & Lymphoma
|
June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use
Carlos Montalban, Victor Abraira, Luca Arcaini, et al.
British Journal of Haematology
|
August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases
Carlos Montalbán, Víctor Abraira, Luca Arcaini, et al.
British Journal of Haematology
|
March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Blood
|
January 24, 2014
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma
Giovanni Franco, Carla Guarnotta, Barbara Frossi, et al.
Cancer Medicine
|
July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Marc P E André, Patrice Carde, Simonetta Viviani, et al.
International Journal of Hematology
|
November 27, 2008
Advanced mast cell disease: an Italian Hematological Multicenter experience
Livio Pagano, Caterina Giovanna Valentini, Morena Caira, et al.
Blood
|
February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical use
Luca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Page
of 7